Shrijana Bista
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shrijana Bista has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Prabin Dawadi
Department of Biology, University of Mississippi
3 shared publications Arun Bahadur Chand
Department of Microbiology, KIST Medical College and Teaching Hospital, Lalitpur, Nepal
2 shared publicationsDev Raj Joshi
Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal
2 shared publications- Dev Raj Joshi
Central Department of Microbiology, Tribhuvan University, Kathmandu, Nepal
2 shared publications Gopiram Syangtan
Shi-Gan International College of Science and Technology, Tribhuvan University, Kathmandu, Nepal
2 shared publications- Gopiram Syangtan
Shi-Gan International College of Science and Technology (SICOST), Tribhuvan University, Kathmandu, Nepal
2 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Phenotypic and molecular characterization of carbapenem resistance among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Acinetobacter baumannii (CRAB) were listed on the WHO bacterial priority pathogens list in 2017. These gram-negative bacteria often cause healthcare-associated infections (HAIs), which pose an increasing threat to public health. This study aimed to isolate and identify CRPAs and CRABs from a tertiary care hospital in central Nepal and characterize carbapenem resistance genes at the molecular level. Materials and methods: A total of 59 isolates, including 27 Pseudomonas aeruginosa and 32 Acinetobacter baumannii , were collected from different clinical samples from April 2021 to December 2022. Antibiotic susceptibility was determined via the Kirby disc diffusion method. The modified carbapenem inactivation method (mCIM) was used for phenotypic confirmation of carbapenem resistance. Conventional polymerase chain reaction (PCR) was used to detect carbapenem resistance genes. Results: Among the 59 isolates, 76.3% were multidrug resistant (MDR), 63.0% were extended-spectrum beta-lactamase (ESBL), and 62.7% were carbapenem resistant. Among the carbapenem-resistant isolates ( n = 37), 75.7% of metallo-beta-lactamase (MBL) producers and 70.3% carried at least one carbapenem resistance gene. The bla CTX−M gene was predominant among the ESBL-positive isolates, present in 58.8% of the P. aeruginosa isolates and 87.5% of the A. baumannii isolates, whereas 29% of both isolates harbored the bla TEM gene. Among the CR-PA isolates, 58.3% carried bla VIM−2 , 16.7% carried bla NDM−1 , and 8.33% carried bla OXA−23 . Among the CR-AB isolates, 56% harbored bla OXA−23 , 32% carried bla NDM−1 , 16% had both bla NDM−1 and bla OXA−23 , and 8% contained both bla OXA−58 and bla OXA−23 . Conclusion: This study highlights a significant burden of MDR and carbapenem-resistant P. aeruginosa and A. baumannii , with the co-occurrence of carbapenem resistance genes, in a clinical setting in Nepal. Our findings suggest that active surveillance of antibiotic resistance in pathogens could inform clinicians and healthcare providers about the treatment of infections.
- 8 July 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Open AccessPhenotypic and molecular characterization of carbapenem resistance among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Acinetobacter baumannii (CRAB) were listed on the WHO bacterial priority pathogens list in 2017. These gram-negative bacteria often cause healthcare-associated infections (HAIs), which pose an increasing threat to public health. This study aimed to isolate and identify CRPAs and CRABs from a tertiary care hospital in central Nepal and characterize carbapenem resistance genes at the molecular level. Materials and methods: A total of 59 isolates, including 27 Pseudomonas aeruginosa and 32 Acinetobacter baumannii , were collected from different clinical samples from April 2021 to December 2022. Antibiotic susceptibility was determined via the Kirby disc diffusion method. The modified carbapenem inactivation method (mCIM) was used for phenotypic confirmation of carbapenem resistance. Conventional polymerase chain reaction (PCR) was used to detect carbapenem resistance genes. Results: Among the 59 isolates, 76.3% were multidrug resistant (MDR), 63.0% were extended-spectrum beta-lactamase (ESBL), and 62.7% were carbapenem resistant. Among the carbapenem-resistant isolates ( n = 37), 75.7% of metallo-beta-lactamase (MBL) producers and 70.3% carried at least one carbapenem resistance gene. The bla CTX−M gene was predominant among the ESBL-positive isolates, present in 58.8% of the P. aeruginosa isolates and 87.5% of the A. baumannii isolates, whereas 29% of both isolates harbored the bla TEM gene. Among the CR-PA isolates, 58.3% carried bla VIM−2 , 16.7% carried bla NDM−1 , and 8.33% carried bla OXA−23 . Among the CR-AB isolates, 56% harbored bla OXA−23 , 32% carried bla NDM−1 , 16% had both bla NDM−1 and bla OXA−23 , and 8% contained both bla OXA−58 and bla OXA−23 . Conclusion: This study highlights a significant burden of MDR and carbapenem-resistant P. aeruginosa and A. baumannii , with the co-occurrence of carbapenem resistance genes, in a clinical setting in Nepal. Our findings suggest that active surveillance of antibiotic resistance in pathogens could inform clinicians and healthcare providers about the treatment of infections.
- Open Access
- 21 January 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 53 (5) , 588-595
Robotic versus manual disinfection of global priority pathogens at COVID-19-dedicated hospitals
- 21 January 2025
- Published by Elsevier in American Journal of Infection Control
- Vol. 53 (5) , 588-595
Open AccessRobotic versus manual disinfection of global priority pathogens at COVID-19-dedicated hospitals
- Open Access
- 29 July 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (07) , 1010-1019
Panton-Valentine leucocidin gene in methicillin resistant Staphylococcus aureus isolated from tertiary care hospital in Nepal
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) expresses the Panton-Valentine leukocidin (PVL) virulence gene, which is associated with community and hospital-acquired severe MRSA infections. The objective of this study was to determine the prevalence and antibiotic susceptibility profile with a focus on the presence of the PVL gene among MRSA isolates in healthcare settings. Methodology: A total of 1,207 clinical specimens and 304 hospital environment swabs were collected in a tertiary care hospital in Nepal, and investigated following basic microbiological techniques. S. aureus was confirmed with the coagulase test. An antibiotic susceptibility test (AST) was performed by the Kirby-Bauer method and screening for MRSA was carried out by the cefoxitin disc diffusion method guided by the Clinical and Laboratory Standards Institute (CLSI), 2020. DNA was extracted and used in a polymerase chain reaction (PCR) to detect mecA and PVL genes. Results: Of the 1,511 samples, 45 (2.9%) S. aureus (23 clinical and 22 environmental) were isolated. Among them, 69.6% (16/23) and 27.3% (6/22) were MRSA in clinical and environmental isolates, respectively. Twelve (52.2%) clinical isolates and seven (31.8%) environmental isolates were multidrug resistant. The majority of isolates were susceptible to vancomycin and linezolid. The PVL gene was detected in 18.2% (n = 4/22) of the MRSA isolates, of which three were from clinical sources and one was from an environmental swab. Conclusions: The prevalence of MRSA, and PVL-producing S. aureus were higher in the hospital setting. Hence, immediate and urgent implementation of infection control and sanitation measures are needed in the hospital.
- 29 July 2024
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 18 (07) , 1010-1019
Open AccessPanton-Valentine leucocidin gene in methicillin resistant Staphylococcus aureus isolated from tertiary care hospital in Nepal
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) expresses the Panton-Valentine leukocidin (PVL) virulence gene, which is associated with community and hospital-acquired severe MRSA infections. The objective of this study was to determine the prevalence and antibiotic susceptibility profile with a focus on the presence of the PVL gene among MRSA isolates in healthcare settings. Methodology: A total of 1,207 clinical specimens and 304 hospital environment swabs were collected in a tertiary care hospital in Nepal, and investigated following basic microbiological techniques. S. aureus was confirmed with the coagulase test. An antibiotic susceptibility test (AST) was performed by the Kirby-Bauer method and screening for MRSA was carried out by the cefoxitin disc diffusion method guided by the Clinical and Laboratory Standards Institute (CLSI), 2020. DNA was extracted and used in a polymerase chain reaction (PCR) to detect mecA and PVL genes. Results: Of the 1,511 samples, 45 (2.9%) S. aureus (23 clinical and 22 environmental) were isolated. Among them, 69.6% (16/23) and 27.3% (6/22) were MRSA in clinical and environmental isolates, respectively. Twelve (52.2%) clinical isolates and seven (31.8%) environmental isolates were multidrug resistant. The majority of isolates were susceptible to vancomycin and linezolid. The PVL gene was detected in 18.2% (n = 4/22) of the MRSA isolates, of which three were from clinical sources and one was from an environmental swab. Conclusions: The prevalence of MRSA, and PVL-producing S. aureus were higher in the hospital setting. Hence, immediate and urgent implementation of infection control and sanitation measures are needed in the hospital.
- 7 February 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (2) , 283-290
Assessment of Antibiotic Resistance among Clinical Isolates of Enterobacteriaceae in Nepal
: Clinicians face a global challenge treating infections caused by Enterobacteriaceae because of the high rate of antibiotic resistance. This cross-sectional study from the Nepal Armed Police Force Hospital, Kathmandu, Nepal, characterized resistance patterns in Enterobacteriaceae across different antimicrobial classes and assessed incidences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections. Enterobacteriaceae from clinical samples were isolated on blood and MacConkey agar, except for urine samples on cysteine lactose electrolyte–deficient agar. To determine antimicrobial susceptibility patterns, including MDR and XDR, the Kirby-Bauer disc diffusion method was used. Statistics were performed using SPSS, v. 17.0. Members of the family were identified in 14.5% (95% CI: 16.2–12.8%) of the total samples (N = 1,617), primarily in urine (54.7%, 128/234), blood (19.7%, 46/234), and sputum (15.0%, 35/234). Escherichia coli (n = 118, 44.2%) was the most predominant bacteria, followed by Citrobacter freundii (n = 81, 30.3%). As much as 95.6% (392/410) of the isolates were penicillin-resistant, whereas only 36.2% (290/801) were carbapenem-resistant. A total of 96 (36.0%) MDR and 98 (36.7%) XDR Enterobacteriaceae were identified. Proteus mirabilis (44.4%, 8/18) predominated MDR cultures, whereas C. freundii (53.1%, 43/81) predominated XDR cultures. Multidrug resistant (38.4%, 71/154) and XDR Enterobacteriaceae (22.7%, 35/154) were chiefly uropathogens. Fluoroquinolone resistance rates in non-MDR, MDR, and XDR isolates were 19.9%, 63.2%, and 96.2%, respectively, whereas cephalosporin resistance rates were 28.6%, 72.9%, and 95.4% and penicillin resistance rates were 67.0%, 97.4%, and 98.0%. One-seventh of patients visiting the hospital were found to be infected with Enterobacteriaceae, and of these patients, at least one-fourth were infected with MDR strains.
- 7 February 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (2) , 283-290
Assessment of Antibiotic Resistance among Clinical Isolates of Enterobacteriaceae in Nepal
: Clinicians face a global challenge treating infections caused by Enterobacteriaceae because of the high rate of antibiotic resistance. This cross-sectional study from the Nepal Armed Police Force Hospital, Kathmandu, Nepal, characterized resistance patterns in Enterobacteriaceae across different antimicrobial classes and assessed incidences of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections. Enterobacteriaceae from clinical samples were isolated on blood and MacConkey agar, except for urine samples on cysteine lactose electrolyte–deficient agar. To determine antimicrobial susceptibility patterns, including MDR and XDR, the Kirby-Bauer disc diffusion method was used. Statistics were performed using SPSS, v. 17.0. Members of the family were identified in 14.5% (95% CI: 16.2–12.8%) of the total samples (N = 1,617), primarily in urine (54.7%, 128/234), blood (19.7%, 46/234), and sputum (15.0%, 35/234). Escherichia coli (n = 118, 44.2%) was the most predominant bacteria, followed by Citrobacter freundii (n = 81, 30.3%). As much as 95.6% (392/410) of the isolates were penicillin-resistant, whereas only 36.2% (290/801) were carbapenem-resistant. A total of 96 (36.0%) MDR and 98 (36.7%) XDR Enterobacteriaceae were identified. Proteus mirabilis (44.4%, 8/18) predominated MDR cultures, whereas C. freundii (53.1%, 43/81) predominated XDR cultures. Multidrug resistant (38.4%, 71/154) and XDR Enterobacteriaceae (22.7%, 35/154) were chiefly uropathogens. Fluoroquinolone resistance rates in non-MDR, MDR, and XDR isolates were 19.9%, 63.2%, and 96.2%, respectively, whereas cephalosporin resistance rates were 28.6%, 72.9%, and 95.4% and penicillin resistance rates were 67.0%, 97.4%, and 98.0%. One-seventh of patients visiting the hospital were found to be infected with Enterobacteriaceae, and of these patients, at least one-fourth were infected with MDR strains.
- Open Access
Emergence of IS Aba1 -linked oxacillinase genes among carbapenem resistant Acinetobacter baumannii isolates in a tertiary cardiac center, Nepal
Insertion sequence contributes to the emergence of carbapenem resistance by dissemination of carbapenemase genes and providing promoter for their overexpression. This study aims to ascertain the occurrence of IS Aba1 -linked OXA carbapenemase genes and its relevance to carbapenem resistance level in Acinetobacter baumannii . This hospital based descriptive study was conducted at Shahid Gangalal National Heart Center, Kathmandu, Nepal. An overall of 1,291 clinical specimens received for routine culture and antibiotic susceptibility testing throughout the study period were included in this study. Identification of Acinetobacter baumannii was validated through detection of intrinsic bla OXA-51-like gene by polymerase chain reaction (PCR). Antibiotic susceptibility was tested by Kirby-Bauer disc diffusion approach and minimum inhibitory concentration (MIC) of meropenem was assessed through agar dilution method. Uniplex PCR assays were performed to detect genes encoding oxacillinases and IS Aba1 . Upstream association of insertion element, IS Aba1 to oxacillinase genes was assessed through PCR mapping strategy using IS Aba1 F and OXA-51R/OXA-23R primers. Out of the 340 bacteria isolated, only 40 (11.8%) were Acinetobacter baumannii . All isolates were resistant against meropenem with MIC value ranging from 16-256 μg/ml. bla OXA-23-like genes was present in every isolate but bla OXA-58 in just two isolates (5%). All isolates had IS Aba1 either above bla OXA-23-like or bla OXA-51-like gene. Higher MIC 90 value of meropenem (243.20 μg/ml) was found in A . baumannii cluster with IS Aba1 -linked upstream to both bla OXA-23-like and bla OXA-51-like genes, thus depicting their eminent role to enhanced carbapenem resistance. Acinetobacter baumannii isolates with IS Aba1 -linked oxacillinase genes are rapidly emerging in clinical settings of Nepal. Thus, medical communities need to be prepared and enable targeted approaches for managing burgeoning problem of carbapenem resistance.
Open AccessEmergence of IS Aba1 -linked oxacillinase genes among carbapenem resistant Acinetobacter baumannii isolates in a tertiary cardiac center, Nepal
Insertion sequence contributes to the emergence of carbapenem resistance by dissemination of carbapenemase genes and providing promoter for their overexpression. This study aims to ascertain the occurrence of IS Aba1 -linked OXA carbapenemase genes and its relevance to carbapenem resistance level in Acinetobacter baumannii . This hospital based descriptive study was conducted at Shahid Gangalal National Heart Center, Kathmandu, Nepal. An overall of 1,291 clinical specimens received for routine culture and antibiotic susceptibility testing throughout the study period were included in this study. Identification of Acinetobacter baumannii was validated through detection of intrinsic bla OXA-51-like gene by polymerase chain reaction (PCR). Antibiotic susceptibility was tested by Kirby-Bauer disc diffusion approach and minimum inhibitory concentration (MIC) of meropenem was assessed through agar dilution method. Uniplex PCR assays were performed to detect genes encoding oxacillinases and IS Aba1 . Upstream association of insertion element, IS Aba1 to oxacillinase genes was assessed through PCR mapping strategy using IS Aba1 F and OXA-51R/OXA-23R primers. Out of the 340 bacteria isolated, only 40 (11.8%) were Acinetobacter baumannii . All isolates were resistant against meropenem with MIC value ranging from 16-256 μg/ml. bla OXA-23-like genes was present in every isolate but bla OXA-58 in just two isolates (5%). All isolates had IS Aba1 either above bla OXA-23-like or bla OXA-51-like gene. Higher MIC 90 value of meropenem (243.20 μg/ml) was found in A . baumannii cluster with IS Aba1 -linked upstream to both bla OXA-23-like and bla OXA-51-like genes, thus depicting their eminent role to enhanced carbapenem resistance. Acinetobacter baumannii isolates with IS Aba1 -linked oxacillinase genes are rapidly emerging in clinical settings of Nepal. Thus, medical communities need to be prepared and enable targeted approaches for managing burgeoning problem of carbapenem resistance.
- Open Access
- 11 October 2021
- Published by Wiley in Veterinary Medicine International
- Vol. 2021, 1-5
Prevalence of Colistin-Resistant Escherichia coli from Poultry in South Asian Developing Countries
Background. Antimicrobial resistance has become a huge problem in animal and public health worldwide. Inadvertent use of antibiotics in poultry has led to the emergence of resistance against many antibiotics, even to last resort of drugs like colistin. Aim. This study aimed to provide uniform quantitative estimate on the percentage prevalence of E. coli as well as to analyze their colistin resistance in poultry in South Asian developing countries. Methods. Two electronic databases, PubMed and Research4Life, were used to search studies as per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The pooled data on the prevalence of E. coli and colistin resistance were analyzed. Results. In the meta-analysis of 9 studies in South Asian region (Nepal, Bangladesh, Pakistan, and India), the pooled prevalence of E. coli was 73 (95 CI, 0.5490.916). The pooled prevalence of colistin resistance against E. coli from poultry was found to be 28 (95 CI, 0.1580.438). Conclusion. There is high prevalence of E. coli and their resistance rate against colistin in poultry. Therefore, antimicrobials in raising livestock should be supervised.
- 11 October 2021
- Published by Wiley in Veterinary Medicine International
- Vol. 2021, 1-5
Open AccessPrevalence of Colistin-Resistant Escherichia coli from Poultry in South Asian Developing Countries
Background. Antimicrobial resistance has become a huge problem in animal and public health worldwide. Inadvertent use of antibiotics in poultry has led to the emergence of resistance against many antibiotics, even to last resort of drugs like colistin. Aim. This study aimed to provide uniform quantitative estimate on the percentage prevalence of E. coli as well as to analyze their colistin resistance in poultry in South Asian developing countries. Methods. Two electronic databases, PubMed and Research4Life, were used to search studies as per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The pooled data on the prevalence of E. coli and colistin resistance were analyzed. Results. In the meta-analysis of 9 studies in South Asian region (Nepal, Bangladesh, Pakistan, and India), the pooled prevalence of E. coli was 73 (95 CI, 0.5490.916). The pooled prevalence of colistin resistance against E. coli from poultry was found to be 28 (95 CI, 0.1580.438). Conclusion. There is high prevalence of E. coli and their resistance rate against colistin in poultry. Therefore, antimicrobials in raising livestock should be supervised.